After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Becton Dickinson & Co. is listed on the NYSE in the Healthcare sector while operating in the Medical Instruments & Supplies industry. The current market capitalization of Becton Dickinson & Co. is $68.65B. A total of 1.73 million shares were traded on the day, compared to an average of 1.58M shares.
In the most recent transaction, Garrison Michael David sold 1,239 shares of BDX for 232.46 per share on Dec 11 ’23. After the transaction, the EVP & President Medical now owns 7,274 company shares. In a previous transaction on Nov 28 ’23, Byrd Richard sold 2,156 shares at 238.47 per share. BDX shares that EVP & President Interventional owns now total 4,120.
Among the insiders who sold shares, Byrd Richard disposed of 459 shares on Sep 05 ’23 at a per-share price of $274.48. This resulted in the EVP & President Interventional holding 3,444 shares of BDX after the transaction. In another insider transaction, Fraser Claire sold 848 shares at $281.66 per share on Aug 28 ’23. Company shares held by the Director now total 21,608.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Becton Dickinson & Co. pays an annual dividend of $4.63, resulting in a dividend yield of 1.95%, and it has a price to earnings (P/E) ratio of 56.20. BDX’s most recent ex-dividend date was 3/7/2024 when it declared a $0.95 quarterly dividend that was paid in cash on 3/29/2024. Previously, the company paid the dividend on 12/29/2023 with an ex-dividend date of 12/7/2023. The BDX stock dividend was $0.95 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, BDX has a high of $287.32 and a low of $228.62.
As of this writing, BDX has an earnings estimate of $2.96 per share for the current quarter. EPS was calculated based on a consensus of 12 estimates, with a high estimate of $2.99 per share and a lower estimate of $2.92. The company reported an EPS of $3.42 in the last quarter, which was -0.30% lower than expectations of $3.43.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BDX’s latest balance sheet shows that the firm has $2.29B in Cash & Short Term Investments as of fiscal 2021. There were $17.61B in debt and $6.63B in liabilities at the time. Its Book Value Per Share was $87.68, while its Total Shareholder’s Equity was $23.68B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BDX is Buy with a score of 4.53.
